Monovaccine (Epstein - Barr virus) Market Overview 2021

A forum to discuss research on the origins of MS and its development.
Post Reply
Tif
Family Elder
Posts: 128
Joined: Fri Sep 13, 2013 7:34 am

Monovaccine (Epstein - Barr virus) Market Overview 2021

Post by Tif »

Hi,

https://www.einnews.com/pr_news/5564526 ... ogy-trends

"SEATTLE, WASHINGTON, UNITED STATES, November 16, 2021 /EINPresswire.com/ -- The increasing research and development activities and funding by various organizations for the development of monovaccine are expected to drive the market growth over the forecast period. Currently, there is no licensed vaccine for Epstein-Barr Virus (EBV). However, various universities and organizations are focusing on developing novel vaccines against EBV and cater to the unmet needs."...

...."Several government organizations from different regions are focusing on the development of novel monovaccines (Epstein - Barr virus) and also focuses on gaining approval from regulatory authorities. For instance, in 2019, researchers from the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) determined how various antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory...."
Top
Post Reply

Return to “MS Etiology and Pathogenesis”